Comparison of the effect of gonadotropin-releasing hormone agonist and dopamine receptor agonist on uterine myoma growth. Histologic, sonographic, and intra …
M Sayyah-Melli, S Tehrani-Gadim… - Saudi medical …, 2009 - europepmc.org
Objective To investigate the effect of 2 medications; Diphereline and Cabergoline, on uterine
leiomyoma growth, and its histologic, sonographic, and intra-operative changes. Methods In
an effort to treat large uterine leiomyoma in symptomatic patients in the Gynecology Clinics
of the Alzahra Teaching Hospital of Tabriz University of Medical Sciences, Tabriz, Iran, from
September 2007 to November 2008, 60 candidates randomized to receive Diphereline 3.75
mg, 4 times every 28 days (group I), and Cabergoline 0.5 mg, once a week for 6 weeks …
leiomyoma growth, and its histologic, sonographic, and intra-operative changes. Methods In
an effort to treat large uterine leiomyoma in symptomatic patients in the Gynecology Clinics
of the Alzahra Teaching Hospital of Tabriz University of Medical Sciences, Tabriz, Iran, from
September 2007 to November 2008, 60 candidates randomized to receive Diphereline 3.75
mg, 4 times every 28 days (group I), and Cabergoline 0.5 mg, once a week for 6 weeks …
Comparison of the effect of gonadotropin-releasing hormone agonist and dopamine receptor agonist on uterine myoma growth. Histologic, sonographic, and intra …
SM Manizheh, TG Sepideh, DT Ali, G Fatemeh… - 2009 - pesquisa.bvsalud.org
To investigate the effect of 2 medications; Diphereline and Cabergoline, on uterine
leiomyoma growth, and its histologic, sonographic, and intra-operative changes. In an effort
to treat large uterine leiomyoma in symptomatic patients in the Gynecology Clinics of the
Alzahra Teaching Hospital of Tabriz University of Medical Sciences, Tabriz, Iran, from
September 2007 to November 2008, 60 candidates randomized to receive Diphereline 3.75
mg, 4 times every 28 days [group I], and Cabergoline 0.5 mg, once a week for 6 weeks …
leiomyoma growth, and its histologic, sonographic, and intra-operative changes. In an effort
to treat large uterine leiomyoma in symptomatic patients in the Gynecology Clinics of the
Alzahra Teaching Hospital of Tabriz University of Medical Sciences, Tabriz, Iran, from
September 2007 to November 2008, 60 candidates randomized to receive Diphereline 3.75
mg, 4 times every 28 days [group I], and Cabergoline 0.5 mg, once a week for 6 weeks …
以上显示的是最相近的搜索结果。 查看全部搜索结果